Evonik is one of the world's leading specialty chemicals companies. Profitable growth and a sustained increase in the value of the company form the heart of their strategy, which is supported by their owners, RAG-Stiftung (74.99 percent) and funds managed by CVC Capital Partners (25.01 percent).
Their specialty chemicals activities focus on high-growth megatrends—especially health, nutrition, resource efficiency, and globalisation—and their goal is to enter attractive future-oriented markets.
In 2011 Evonik’s roughly 33,000 employees generated sales of €14.5 billion and an operating result (EBITDA) of €2.8 billion. More than 70 percent of sales are generated outside Germany, providing convincing evidence that our business is global.
The Aquaculturists
This blog is maintained by The Aquaculturists staff and is supported by the
magazine International Aquafeed which is published by Perendale Publishers Ltd
For additional daily news from aquaculture around the world: aquaculture-news
No comments:
Post a Comment